塞来昔布
药代动力学
生物利用度
体内
药理学
材料科学
药品
析因实验
己内酯
口服
化学
医学
聚合物
复合材料
生物技术
统计
生物
数学
共聚物
作者
Dalia Ghorab,Maha M. Amin,Omneya Mohammed Khowessah,Mina Ibrahim Tadros
出处
期刊:Drug Delivery
[Informa]
日期:2011-07-28
卷期号:18 (7): 523-535
被引量:38
标识
DOI:10.3109/10717544.2011.595841
摘要
Context: Celecoxib suffers from low and variable bioavailability following oral administration of solutions or capsules. Recent studies proved that chemoprevention of colorectal cancer is possible with celecoxib.Objective: This work aimed to tailor colon-targeted celecoxib-loaded microparticles using time-dependant and pH-dependant coats. Estimation of drug pharmacokinetics following oral administration to fasted rats was another goal.Methods: A 23 factorial design was adopted to develop poly-ϵ-caprolactone (PCL) celecoxib-loaded microparticles (F1–F8). To minimize drug-percentages released before colon, another coat of Eudragit® S100 was applied. In vitro characterization of microparticles involved topography, determination of particle size and entrapment efficiency (EE %). Time for 50% drug release (t50%) and drug-percentages released after 2 hours (Q2h) and 4 hours (Q4h) were statistically compared. Estimation of drug pharmacokinetics following oral administration of double-coat microparticles (F10) was studied in rats.Results: PCL-single-coat microparticles were spherical, discrete with a size range of 60.66 ± 4.21–277.20 ± 6.10 μm. Direct correlations were observed between surfactant concentration and EE%, Q2h and Q4h. The PCL M.wt. and drug: PCL ratio had positive influences on EE% and negative impacts on Q2h and Q4h. When compared to the best achieved PCL-single-coat microparticles (F2), the double-coat microparticles (F10) showed satisfactory drug protection; Q2h and Q4h were significantly (P < 0.01) decreased from 31.84 ± 1.98% and 54.72 ± 2.10% to 15.92 ± 1.78% and 26.93 ± 2.76%, respectively. When compared to celecoxib powder, F10 microparticles enhanced the bioavailability and extended the duration of drug-plasma concentration in rats.Conclusion: The developed double-coat microparticles could be considered as a promising celecoxib extended-release colon-targeting system.
科研通智能强力驱动
Strongly Powered by AbleSci AI